Abstract
The aim of the study was to assess the prevalence of moderate to severe psoriasis (MS-P) in patients with psoriatic arthritis (PsA) and the relationship between MS-P and other variables related to arthritis. One hundred sixty-six consecutive patients with PsA periodically monitored at a university hospital’s PsA unit in northeastern Spain were included in the study. Patients with psoriasis were classified as having MS-P when systemic treatment for skin was required. Clinical criteria for treatment indication was BSA >10 and/or PASI >14 and/or psoriasis affecting a very sensitive area of the body. Demographic and clinical data related to arthritis were assessed, including PsA pattern, age of onset of psoriasis and arthritis, disease activity index, and treatment required over the course of the disease. Moderate–severe psoriasis were more prevalent in women (p = 0.027). One hundred nine patients (65.7%) had psoriatic nail disease, and MS-P was more frequent in these patients (40 (77%) vs. 69 (61%), p = 0.028). Patients with spondyloarthropathy were significantly associated with MS-P (7 (16%) vs. 3 (3%), p = 0.014). No statistical association was observed between severe psoriasis and the age of onset of psoriasis or arthritis, involvement of distal interphalangeal joints, laboratory findings (HLA B27, RF), functional class, or disease activity indices. We report a high prevalence of severe psoriasis among patients with psoriatic arthritis, higher in women and patients with psoriatic nail disease and axial spondyloarthropathy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Gladman DD, Antoni C, Mease P, Clegg DO, Nash P (2005) Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis 64(Suppl 2):ii14–ii17
Little H, Harvie JN, Lester RS (1975) Psoriatic arthritis in severe psoriasis. Can Med Assoc J 112:317–319
Reich K, Kruger K, Mossner R, Augustin M (2009) Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis. Br J Dermatol 160:1040–1047
Taylor W, Gladman D, Helliwell P, Marchesoni A, Marchesoni P, Mielants H, CASPARStudy Group (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54(8):2665–2673
Prevoo ML, ‘t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44–48
Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2286–2291
Husted JA, Gladman DD, Long JA, Farewell VT (1995) A modified version of the Health Assessment Questionnaire (HAQ) for psoriatic arthritis. Clin Exp Rheumatol 13:439–443
Calin A, Garrett S, Whitelock H, Kennedy LG, O’Hea J, Mallorie P et al (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21:2281–2285
Fredriksson T, Pettersson U (1978) Severe psoriasis—oral therapy with a new retinoid. Dermatologica 157:238–244
Puig L, Carrascosa JM, Dauden E, Sanchez-Carazo JL, Ferrandiz C, Sanchez-Regana M et al (2009) Spanish evidence-based guidelines on the treatment of moderate-to-severe psoriasis with biologic agents. Actas Dermosifiliogr 100:386–413
Gelfand JM, Gladman DD, Mease PJ, Smith N, Margolis DJ, Nijsten T et al (2005) Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol 53:573
Scarpa R, Oriente P, Pucino A, Torella M, Vignone L, Riccio A et al (1984) Psoriatic arthritis in psoriatic patients. Br J Rheumatol 23:246–250
Stern RS (1985) The epidemiology of joint complaints in patients with psoriasis. J Rheumatol 12:315–320
Leczinsky CG (1948) The incidence of arthropathy in a 10 year series of psoriasis cases. Acta Derm Venereol 28:483–487
Cohen MR, Reda DJ, Clegg DO (1999) Baseline relationships between psoriasis and psoriatic arthritis: analysis of 221 patients with active psoriatic arthritis. Department of Veterans Affairs Cooperative Study Group on Seronegative Spondyloarthropathies. J Rheumatol 26:1752–1756
Wright V, Roberts MC, Hill AG (1979) Dermatological manifestations in psoriatic arthritis: a follow-up study. Acta Derm Venereol 59:235–240
Williamson L, Dalbeth N, Dockerty JL, Gee BC, Weatherall R, Wordsworth BP (2004) Extended report: nail disease in psoriatic arthritis–clinically important, potentially treatable and often overlooked. Rheumatology (Oxford) 43:790–794
Jones SM, Armas JB, Cohen MG, Lovell CR, Evison G, McHugh NJ (1994) Psoriatic arthritis: outcome of disease subsets and relationship of joint disease to nail and skin disease. Br J Rheumatol 33:834–839
Scarpa R, Soscia E, Peluso R, Atteno M, Manguso F, Del Puente A et al (2006) Nail and distal interphalangeal joint in psoriatic arthritis. J Rheumatol 33:1315–1319
Barraclough D, Russell AS, Percy JS (1977) Psoriatic spondylitis: a clinical, radiological, and scintiscan survey. J Rheumatol 4:282–287
Reina SD, del Blanco J, Bonet M, Castano C, Clavaguera T, Mateo L et al (2007) Functional impairment in psoriatic arthritis. Multicentric study of 343 patients. Med Clin (Barc) 129:201–204
Disclosures
None
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Busquets-Pérez, N., Rodriguez-Moreno, J., Gómez-Vaquero, C. et al. Relationship between psoriatic arthritis and moderate–severe psoriasis: analysis of a series of 166 psoriatic arthritis patients selected from a hospital population. Clin Rheumatol 31, 139–143 (2012). https://doi.org/10.1007/s10067-011-1787-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-011-1787-1